Varian Medical Systems - VAR Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$177.07
+0 (0.00%)
Get New Varian Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VAR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VAR

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Varian Medical Systems in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $177.07.

This chart shows the closing price for VAR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Varian Medical Systems. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/1/2021UBS GroupDowngradeBuy ➝ In-LineLow
2/23/2021UBS GroupDowngradeBuy ➝ In-LineLow
12/31/2020UBS GroupDowngradeIn-LineN/A
12/14/2020UBS GroupDowngradeIn-LineLow
12/7/2020UBS GroupDowngradeBuy ➝ In-LineLow
12/7/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$178.00Low
12/1/2020UBS GroupDowngradeIn-LineLow
11/25/2020UBS GroupDowngradeBuy ➝ In-LineLow
11/17/2020UBS GroupDowngradeIn-LineLow
11/11/2020UBS GroupDowngradeBuy ➝ In-LineLow
11/5/2020UBS GroupDowngradeIn-LineLow
10/30/2020UBS GroupDowngradeBuy ➝ In-LineLow
10/28/2020Barrington ResearchDowngradeOutperform ➝ UnderperformLow
10/28/2020Robert W. BairdDowngradeOutperform ➝ Neutral$178.00Low
8/10/2020BTIG ResearchDowngradeBuy ➝ NeutralLow
8/6/2020UBS GroupDowngradeBuy ➝ Neutral$150.00 ➝ $177.50Low
8/3/2020Jefferies Financial GroupBoost TargetBuy$130.00 ➝ $178.00High
8/3/2020BTIG ResearchBoost TargetBuy$133.00 ➝ $177.50High
8/2/2020Piper SandlerDowngradeOverweight ➝ Neutral$142.00 ➝ $177.50High
7/27/2020Piper SandlerBoost TargetOverweight$130.00 ➝ $142.00High
5/5/2020UBS GroupLower TargetBuy$160.00 ➝ $150.00Medium
5/5/2020Barrington ResearchReiterated RatingBuy$147.00 ➝ $137.00High
5/5/2020Piper SandlerBoost TargetOverweight$126.00 ➝ $130.00High
5/4/2020BTIG ResearchReiterated RatingBuy$133.00High
4/19/2020Piper SandlerInitiated CoverageOverweight$126.00High
4/19/2020Evercore ISIDowngradeOutperform ➝ UnderperformHigh
4/17/2020JPMorgan Chase & Co.Lower TargetUnderweight$100.00 ➝ $90.00High
4/9/2020Evercore ISIDowngradeOutperform ➝ Underperform$163.00 ➝ $105.00Low
4/7/2020Piper SandlerInitiated CoverageOverweight$126.00High
4/1/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$171.00 ➝ $114.00High
3/10/2020BTIG ResearchLower Target$157.00 ➝ $143.00High
3/10/2020Barrington ResearchLower Target$160.00 ➝ $147.00High
3/10/2020Robert W. BairdLower TargetOutperform$166.00 ➝ $143.00High
3/10/2020UBS GroupLower TargetBuy$175.00 ➝ $160.00High
2/12/2020The Goldman Sachs GroupInitiated CoverageBuy$171.00Low
1/30/2020Barrington ResearchReiterated RatingOutperform$152.00 ➝ $160.00Low
1/30/2020Robert W. BairdBoost TargetOutperform$158.00 ➝ $166.00Low
1/24/2020BTIG ResearchReiterated RatingBuy$157.00Medium
1/2/2020Evercore ISIUpgradeIn-Line ➝ Outperform$130.00 ➝ $164.00High
12/4/2019UBS GroupBoost TargetBuy$155.00 ➝ $160.00High
11/18/2019Robert W. BairdReiterated RatingBuy$158.00Low
10/24/2019Barrington ResearchBoost TargetOutperform$146.00 ➝ $152.00High
10/21/2019Barrington ResearchSet TargetBuy$146.00High
10/14/2019BTIG ResearchUpgradeNeutral ➝ Buy$130.00Medium
9/23/2019Barrington ResearchBoost TargetOutperform$142.00 ➝ $146.00Low
7/26/2019Robert W. BairdSet TargetBuy$158.00Low
7/25/2019Barrington ResearchReiterated RatingBuy$142.00Medium
7/24/2019BTIG ResearchReiterated RatingHoldLow
5/2/2019CitigroupLower TargetBuy ➝ Buy$174.00 ➝ $165.00Medium
4/25/2019UBS GroupBoost TargetBuy ➝ Buy$150.00 ➝ $158.00Medium
(Data available from 4/19/2019 forward)

News Sentiment Rating

-0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2023
  • 0 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
11/21/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
12/21/2023
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/20/2024
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
2/19/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/20/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
4/19/2024

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Varian Medical Systems logo
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Read More

Today's Range

Now: $177.07
Low: $177.07
High: $177.07

50 Day Range

MA: $177.00
Low: $176.53
High: $177.29

52 Week Range

Now: $177.07
Low: $103.67
High: $177.38

Volume

N/A

Average Volume

746,779 shs

Market Capitalization

$16.26 billion

P/E Ratio

60.43

Dividend Yield

N/A

Beta

1.06

Frequently Asked Questions

What sell-side analysts currently cover shares of Varian Medical Systems?

The following sell-side analysts have issued research reports on Varian Medical Systems in the last year:
View the latest analyst ratings for VAR.

What is the current price target for Varian Medical Systems?

0 Wall Street analysts have set twelve-month price targets for Varian Medical Systems in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Varian Medical Systems in the next year.
View the latest price targets for VAR.

What is the current consensus analyst rating for Varian Medical Systems?

Varian Medical Systems currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VAR.

What other companies compete with Varian Medical Systems?

How do I contact Varian Medical Systems' investor relations team?

Varian Medical Systems' physical mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider's listed phone number is 650-493-4000 and its investor relations email address is [email protected]. The official website for Varian Medical Systems is www.varian.com. Learn More about contacing Varian Medical Systems investor relations.